Ask Warren

Celemics

331920 · KOSDAQ · ₩331920 · 셀레믹스

₩9,230▲ ₩10 (0.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.4B₩923M₩1.7B₩1.3B₩1.1B₩1.7B₩2B₩1.4B
Cost of sales₩834M₩643M₩667M₩842M₩685M₩706M₩922M₩567M
Gross profit₩542M₩280M₩992M₩420M₩439M₩1B₩1.1B₩792M
Operating income−₩924M−₩1.4B−₩456M−₩1.1B−₩1.3B−₩447M−₩141M−₩483M
Net income₩815M−₩6B−₩2.5B₩1.4B−₩640M−₩2.2B₩2.7B−₩2.9B
Net income to shareholders−₩5.2B−₩6B−₩814M₩1.9B−₩2.9B−₩2.2B−₩9.3B₩9.6B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩49B₩23B₩24B₩26B₩24B₩28B₩29B₩39B
Current assets₩41B₩12B₩8.4B₩9.6B₩10B₩12B₩12B₩11B
Cash and equivalents₩37B₩6.7B₩3.2B₩1.6B₩1.7B₩3.1B₩4B₩2.3B
Total liabilities₩18B₩5.4B₩1.4B₩1.9B₩2B₩2.7B₩2.2B₩1.7B
Current liabilities₩1.8B₩1.8B₩1.3B₩1.9B₩1.9B₩2.5B₩2B₩1.4B
Borrowings₩16B₩3.5B₩377M₩266M₩348M₩431M₩518M₩604M
Total equity₩30B₩18B₩23B₩24B₩22B₩25B₩27B₩37B
Shareholders' equity₩30B₩18B₩23B₩24B₩22B₩25B₩27B₩37B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.1B−₩575M−₩773M−₩1B−₩964M−₩829M₩1.6B−₩1.2B
Capital spending₩672,864₩19M₩68M₩20M₩78M₩0₩12M₩79M
Free cash flow−₩1.1B−₩594M−₩841M−₩1.1B−₩1B−₩829M₩1.6B−₩1.2B

Consolidated where available. Amounts in won.

Also known as: Celemics / 셀레믹스 / 331920 / KRX:331920

Source: KRX statistical information